Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BACH1 intronic transcript 1 (BACH1-IT1) is classified as a long noncoding RNA transcribed from an intronic region of the BACH1 gene (BTB domain and CNC homolog 1). It does not encode a protein, and there is currently no well-documented evidence in public molecular databases or the literature attributing any specific biological function, disease role, or druggability to BACH1-IT1. Most research and reviews focus on the protein-coding BACH1 gene, a well-characterized transcription factor, rather than its intronic transcript variants[5][6]. BACH1 intronic transcript 1 (BACH1-IT1) is sometimes conflated with BACH1, the transcription factor with well-studied biological and clinical roles[1][2][3][4][6]. However, BACH1-IT1 itself appears not to be a recognized therapeutic target or biomarker. No information indicates notable function, disease involvement, or drug interactions for BACH1-IT1 in current molecular biology databases or recent literature, underlining potential issues in considering it a target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BACH1 intronic transcript 1 (BACH1-IT1).